In 2023, the re-import of cortisone, hydrocortisone, prednisone, and prednisolone to Italy stood at 597.1 kilograms. Analyzing the forecast from 2024 to 2028, the data shows a steady increase in volume, with minimal year-on-year growth ranging from 0.5% to 0.6%. Over the five-year forecast period, the compound annual growth rate (CAGR) averages around 0.6%. This indicates a stable upward trend, albeit at a modest pace.

Future trends to watch for:

Global supply chain dynamics impacting the availability and pricing of these corticosteroids.
Changes in demand driven by demographic shifts and potential healthcare policy adjustments in Italy and the EU.
Technological advancements in medicine that may introduce alternatives to these specific pharmaceuticals.